CVE-2026-19532: Path Traversal in HAVELSAN's Liman MYS
HAVELSAN Inc. · Liman MYS
Fixed in 2.3.4-1124 · Affected: HAVELSAN Inc. Liman MYS before 2.3.4-1124 · Exploitation: unlikely (under 1%)
Not in CyberSIXT coverage yet: no article names this CVE. This page shows the public record.
Higher than 18% of scored CVEs
DescriptionCVE.org
Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in HAVELSAN Inc. Liman MYS allows Path Traversal. This issue affects Liman MYS: from 2.3.2 before 2.3.4-1124.
Affected products1
From the CVE record. A product or version that is not listed is unknown, not unaffected.
- HAVELSAN Inc. · Liman MYSfrom 2.3.2 before 2.3.4-1124
On the Atlas
Every published CVE is on the CyberSIXT Atlas, grouped by weakness, vendor and month.
- Exploitation
- Unlikely (under 1%). EPSS under 1%, or no score yet.
- CISA KEV
- Not listed
- Public check
- No public nuclei template
- Vendor
- HAVELSAN Inc.
- Published
- September 2026
CoverageNo articles yet
No CyberSIXT article names CVE-2026-19532 yet, so there is no coverage timeline, action brief or change log for it. Everything on this page comes from the public CVE record, CISA KEV, EPSS and the nuclei template index. Search the archive or see the CVEs in the news.